Efficacy and safety of one-month postpartum zidovudine and didanosine to prevent HIV-resistance mutations following intrapartum single-dose nevirapine

BACKGROUND: Intrapartum single-dose-nevirapine along with third trimester maternal and infant zidovudine are essential components of programs to prevent mother-to-child HIV transmission in resource-limited settings. The persistence of nevirapine in the plasma for three weeks postpartum risks selecti...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Lallemant, Marc, Ngo-Giang-Huong, Nicole, Jourdain, Gonzague, Traisaithit, Patrinee, Cressey, Tim R., Collins, Intira J., Jarupanich, Tapnarong, Sukhumanant, Thammanoon, Achalapong, Jullapong, Sabsanong, Prapan, Chotivanich, Nantasak, Winiyakul, Narong, Ariyadej, Surabon, Kanjanasing, Annop, Ratanakosol, Janyaporn, Hemvuttiphan, Jittapol, Kengsakul, Karun, Wannapira, Wiroj, Sittipiyasakul, Veerachai, Pornkitprasarn, Witaya, Liampongsabuddhi, Prateung, McIntosh, Kenneth, Van Dyke, Russell B., Frenkel, Lisa M., Koetsawang, Suporn, Le Coeur, Sophie
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2010
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2922986/
https://ncbi.nlm.nih.gov/pubmed/20158398
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/650745
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi